NCT00475098View on ClinicalTrials.gov

Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT)

PHASE3CompletedINTERVENTIONAL
Enrollment

553

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Lung CancerNon Small Cell Lung Cancer
Interventions
DRUG

Tinzaparin sodium 100 UI/Kg/OD for 12 weeks

treatment in lung tumours

Trial Locations (1)

75015

Hopital Européen Georges Pompidou, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00475098 - Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT) | Biotech Hunter | Biotech Hunter